2009. Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss Medical Weekly. 139, 1112 (Mar. 2009), 173–173. DOI:https://doi.org/10.4414/smw.2009.12381.